GLOBUS MEDICAL INC - Class A Stock (GMED)

CUSIP: 379577208

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Class A Stock
Shares outstanding
115,244,363
Total 13F shares
113,402,229
Share change
+6,695,815
Total reported value
$6,082,679,016
Put/Call ratio
48%
Price per share
$53.64
Number of holders
435
Value change
+$359,376,321
Number of buys
214
Number of sells
189

Quarterly Holders Quick Answers

What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2024

As of 31 Mar 2024, GLOBUS MEDICAL INC - Class A Stock (GMED) was held by 435 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 113,402,229 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, Champlain Investment Partners, LLC, Camber Capital Management LP, Burgundy Asset Management Ltd., and HAWK RIDGE CAPITAL MANAGEMENT LP. This page lists 436 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.